IT'S rather sad to see how often medical drugs crop up as a source of scandal and conflict in Papua New Guinea.
In recent times there has been the controversy surrounding the appointment of a manufacturer who PNG’s doctors, and others qualified to pass judgement, alleged was unable to meet global quality assurance standards.
The tender process for that decision also seemed unable to pass muster, despite being vigoously defended by Health Minister Malabag.
The PNG government professed to be unconcerned about either of these malfunctions in the system.
And while the Australian government said nothing, it did withdraw millions of dollars it had on offer for purchasing drugs.